vs
FREQUENCY ELECTRONICS INC（FEIM）与Protalix BioTherapeutics, Inc.（PLX）财务数据对比。点击上方公司名可切换其他公司
FREQUENCY ELECTRONICS INC的季度营收约是Protalix BioTherapeutics, Inc.的1.9倍（$17.1M vs $9.1M），FREQUENCY ELECTRONICS INC净利率更高（10.5% vs -60.3%，领先70.9%），FREQUENCY ELECTRONICS INC同比增速更快（8.3% vs -49.9%），Protalix BioTherapeutics, Inc.自由现金流更多（$1.6M vs $-1.1M），过去两年FREQUENCY ELECTRONICS INC的营收复合增速更高（11.8% vs -6.7%）
超电子控股是一家英国国防与安全企业，曾在伦敦证券交易所上市，是富时250指数成分股之一，后被隶属于安宏资本的科巴姆公司收购。
Protalix BioTherapeutics是一家以色列制药企业，核心产品为植物源酶制剂他利苷酶阿尔法，该产品已获美国食品药品监督管理局批准，用于治疗戈谢病，专注于开发创新生物技术药物服务患者需求。
FEIM vs PLX — 直观对比
营收规模更大
FEIM
是对方的1.9倍
$9.1M
营收增速更快
FEIM
高出58.2%
-49.9%
净利率更高
FEIM
高出70.9%
-60.3%
自由现金流更多
PLX
多$2.8M
$-1.1M
两年增速更快
FEIM
近两年复合增速
-6.7%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $17.1M | $9.1M |
| 净利润 | $1.8M | $-5.5M |
| 毛利率 | 38.2% | 49.4% |
| 营业利润率 | 10.0% | -51.1% |
| 净利率 | 10.5% | -60.3% |
| 营收同比 | 8.3% | -49.9% |
| 净利润同比 | -32.1% | -184.8% |
| 每股收益（稀释后） | $0.18 | $-0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FEIMPLX
| Q4 25 | $17.1M | $9.1M | ||
| Q3 25 | $13.8M | $17.9M | ||
| Q2 25 | $20.0M | $15.7M | ||
| Q1 25 | $18.9M | $10.1M | ||
| Q4 24 | $15.8M | $18.2M | ||
| Q3 24 | $15.1M | $18.0M | ||
| Q2 24 | $15.6M | $13.5M | ||
| Q1 24 | $13.7M | — |
净利润FEIMPLX
| Q4 25 | $1.8M | $-5.5M | ||
| Q3 25 | $634.0K | $2.4M | ||
| Q2 25 | $3.2M | $164.0K | ||
| Q1 25 | $15.4M | $-3.6M | ||
| Q4 24 | $2.7M | $6.5M | ||
| Q3 24 | $2.4M | $3.2M | ||
| Q2 24 | $2.6M | $-2.2M | ||
| Q1 24 | $130.0K | — |
毛利率FEIMPLX
| Q4 25 | 38.2% | 49.4% | ||
| Q3 25 | 36.8% | 53.4% | ||
| Q2 25 | 37.5% | 62.5% | ||
| Q1 25 | 43.8% | 19.1% | ||
| Q4 24 | 48.2% | 78.7% | ||
| Q3 24 | 44.4% | 53.4% | ||
| Q2 24 | 40.3% | 29.8% | ||
| Q1 24 | 22.6% | — |
营业利润率FEIMPLX
| Q4 25 | 10.0% | -51.1% | ||
| Q3 25 | 2.6% | 11.9% | ||
| Q2 25 | 16.4% | 7.5% | ||
| Q1 25 | 18.3% | -41.0% | ||
| Q4 24 | 16.5% | 39.6% | ||
| Q3 24 | 15.7% | 22.2% | ||
| Q2 24 | 16.0% | -18.0% | ||
| Q1 24 | -3.4% | — |
净利率FEIMPLX
| Q4 25 | 10.5% | -60.3% | ||
| Q3 25 | 4.6% | 13.2% | ||
| Q2 25 | 16.0% | 1.0% | ||
| Q1 25 | 81.4% | -35.8% | ||
| Q4 24 | 16.8% | 35.6% | ||
| Q3 24 | 16.1% | 18.0% | ||
| Q2 24 | 16.9% | -16.4% | ||
| Q1 24 | 0.9% | — |
每股收益（稀释后）FEIMPLX
| Q4 25 | $0.18 | $-0.06 | ||
| Q3 25 | $0.07 | $0.03 | ||
| Q2 25 | $0.33 | $0.00 | ||
| Q1 25 | $1.60 | $-0.05 | ||
| Q4 24 | $0.28 | $0.10 | ||
| Q3 24 | $0.25 | $0.03 | ||
| Q2 24 | $0.28 | $-0.03 | ||
| Q1 24 | $0.01 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.0M | $14.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $58.5M | $48.2M |
| 总资产 | $92.3M | $82.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FEIMPLX
| Q4 25 | $3.0M | $14.7M | ||
| Q3 25 | $4.5M | $13.6M | ||
| Q2 25 | $4.7M | $17.9M | ||
| Q1 25 | $5.5M | $19.5M | ||
| Q4 24 | $9.7M | $19.8M | ||
| Q3 24 | $16.2M | $27.4M | ||
| Q2 24 | $18.3M | $23.4M | ||
| Q1 24 | $11.7M | — |
股东权益FEIMPLX
| Q4 25 | $58.5M | $48.2M | ||
| Q3 25 | $56.3M | $52.9M | ||
| Q2 25 | $55.6M | $49.9M | ||
| Q1 25 | $51.8M | $45.2M | ||
| Q4 24 | $36.2M | $43.2M | ||
| Q3 24 | $33.2M | $32.4M | ||
| Q2 24 | $39.8M | $28.6M | ||
| Q1 24 | $36.7M | — |
总资产FEIMPLX
| Q4 25 | $92.3M | $82.3M | ||
| Q3 25 | $93.2M | $82.3M | ||
| Q2 25 | $93.7M | $78.5M | ||
| Q1 25 | $86.4M | $73.9M | ||
| Q4 24 | $77.8M | $73.4M | ||
| Q3 24 | $84.3M | $61.6M | ||
| Q2 24 | $83.3M | $91.5M | ||
| Q1 24 | $77.7M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-523.0K | $2.0M |
| 自由现金流经营现金流 - 资本支出 | $-1.1M | $1.6M |
| 自由现金流率自由现金流/营收 | -6.6% | 17.8% |
| 资本支出强度资本支出/营收 | 3.6% | 4.4% |
| 现金转化率经营现金流/净利润 | -0.29× | — |
| 过去12个月自由现金流最近4个季度 | $-5.5M | $-13.6M |
8季度趋势，按日历期对齐
经营现金流FEIMPLX
| Q4 25 | $-523.0K | $2.0M | ||
| Q3 25 | $1.2M | $-3.7M | ||
| Q2 25 | $-155.0K | $-5.2M | ||
| Q1 25 | $-3.6M | $-5.1M | ||
| Q4 24 | $3.8M | $4.0M | ||
| Q3 24 | $-1.5M | $4.1M | ||
| Q2 24 | $7.5M | $-3.6M | ||
| Q1 24 | $4.2M | — |
自由现金流FEIMPLX
| Q4 25 | $-1.1M | $1.6M | ||
| Q3 25 | $385.0K | $-4.2M | ||
| Q2 25 | $-786.0K | $-5.7M | ||
| Q1 25 | $-4.0M | $-5.4M | ||
| Q4 24 | $3.3M | $3.6M | ||
| Q3 24 | $-1.8M | $4.0M | ||
| Q2 24 | $6.7M | $-3.8M | ||
| Q1 24 | $3.9M | — |
自由现金流率FEIMPLX
| Q4 25 | -6.6% | 17.8% | ||
| Q3 25 | 2.8% | -23.7% | ||
| Q2 25 | -3.9% | -36.2% | ||
| Q1 25 | -20.9% | -53.0% | ||
| Q4 24 | 20.8% | 19.6% | ||
| Q3 24 | -11.8% | 22.4% | ||
| Q2 24 | 42.8% | -28.1% | ||
| Q1 24 | 28.4% | — |
资本支出强度FEIMPLX
| Q4 25 | 3.6% | 4.4% | ||
| Q3 25 | 5.6% | 2.8% | ||
| Q2 25 | 3.2% | 2.8% | ||
| Q1 25 | 1.7% | 3.0% | ||
| Q4 24 | 3.3% | 2.3% | ||
| Q3 24 | 2.2% | 0.5% | ||
| Q2 24 | 5.3% | 1.3% | ||
| Q1 24 | 2.3% | — |
现金转化率FEIMPLX
| Q4 25 | -0.29× | — | ||
| Q3 25 | 1.83× | -1.58× | ||
| Q2 25 | -0.05× | -31.91× | ||
| Q1 25 | -0.24× | — | ||
| Q4 24 | 1.44× | 0.61× | ||
| Q3 24 | -0.60× | 1.27× | ||
| Q2 24 | 2.85× | — | ||
| Q1 24 | 32.36× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FEIM
| POC Revenue | $14.8M | 86% |
| POT Revenue | $2.3M | 13% |
PLX
| Products | $8.7M | 95% |
| Other | $428.0K | 5% |
